Transplant programs frequently focus on volume, outcomes, access, and growth while one of their most important financial processes receives far less operational attention: the Medicare cost report.
For Medicare-certified transplant programs, organ-acquisition costs are treated differently from the routine inpatient payment associated with the transplant hospitalization. CMS provides a specific cost-reporting structure for accumulating and determining allowable organ-acquisition costs, including Worksheet D-4.
The challenge is that the cost report is only as accurate as the operational information feeding it.
When Operations and Finance Become Disconnected
Transplant activity crosses numerous departments: transplant administration; donor evaluation; HLA and histocompatibility services; operating rooms; imaging; laboratories; pharmacy; organ preservation; transportation; outside organ procurement; living donor services; and clinical personnel supporting acquisition activity.
CMS instructions recognize a range of direct organ-acquisition costs, including certain physician services, organs acquired from other providers or OPOs, organ transportation, organ-recovery surgical services, and tissue-typing services.
When these activities are not identified, mapped, allocated, or documented appropriately, the cost report may fail to reflect the actual resources required to support transplantation.
Common Areas Worth Reviewing
A rigorous prospective review should examine whether the operational structure matches the cost-report structure.
Organ-specific cost centers. Costs should be captured consistently and assigned to the appropriate organ-acquisition activity.
Personnel and time allocation. Programs should evaluate whether documented time and FTE allocation reasonably reflect actual allowable acquisition-related work.
HLA and laboratory costs. High-cost testing environments warrant careful reconciliation.
Living donor activity. Donor-related services require clear identification and appropriate accounting.
Deceased donor invoices and outside organ acquisition. Invoices should be reconciled against activity and appropriately captured.
Preservation and procurement technology. New organ-preservation technologies can introduce significant expenses that require thoughtful accounting and documentation.
Square footage and overhead allocation. Dedicated transplant resources should be evaluated within the hospital's cost-finding methodology.
The purpose is not to maximize reimbursement through aggressive classification. It is to ensure that the cost report accurately represents allowable activity and that the documentation can support the amounts reported.
Benchmarking Adds Context
A single cost report tells a program what it reported. Benchmarking can help leadership understand how that reporting compares with peers.
Differences in organ-acquisition cost, Medicare utilization, cost per transplant, staffing allocation, and other measures can identify areas requiring further investigation. A benchmark is not proof that a program is right or wrong; transplant programs differ substantially in volume, complexity, geography, organ mix, and operating model.
But an outlier can be a useful question.
Prospective Review Is More Powerful Than Retrospective Discovery
Many cost-report problems are discovered after submission, when correcting them becomes more difficult.
A stronger model brings transplant operations, finance, reimbursement, and hospital leadership together before submission.
The goal is reconciliation: Does the report reflect how the program actually operates? Can the major costs be traced? Are allocation methodologies defensible? Do organ volumes and acquisition activity reconcile? Are supporting records available?
Financial stewardship in transplantation requires more than controlling expense. It requires ensuring that allowable costs are accurately identified, documented, and reported.
For transplant leaders, Medicare cost-report literacy is therefore not merely a finance competency. It is part of responsible program leadership.
